Clinical trial programme resumes after safety concerns
Company will manufacture over 25% more doses than previously planned
Deals agreed with Janssen and Novavax for another 90 million doses
Updated Date: Thu, 06 Aug 2020 00:00:00 EDT
Updated Date: Thu, 06 Aug 2020 00:00:00 EDT
Updated Date: Thu, 06 Aug 2020 00:00:00 EDT
On heels of U.S. pact, Johnson & Johnson strikes a double-size COVID vaccine deal with Europe esagonowsky Thu, […]
Antibiotic resistance is an increasing health problem, but new research suggests it is not only caused by the […]
A multiple sclerosis drug may be used to block HIV infection and reduce the latent reservoir, according to […]
A month after the “urgent” review promised by England’s health secretary, Public Health England (PHE) has announced new […]